Detalles de la búsqueda
1.
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
Clin Infect Dis
; 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376212
2.
Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19.
J Med Virol
; 96(3): e29541, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38516779
3.
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.
JAMA
; 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762798
4.
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
Am J Respir Crit Care Med
; 206(6): 730-739, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580040
5.
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
Ann Intern Med
; 175(10): 1401-1410, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36037469
6.
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
J Infect Dis
; 226(12): 2129-2136, 2022 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35576581
7.
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients.
BMC Infect Dis
; 22(1): 818, 2022 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36344927
8.
Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials.
Crit Care Med
; 49(11): 1963-1973, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34495876
9.
Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care. NHLBI Working Group Report.
Am J Respir Crit Care Med
; 202(4): 511-523, 2020 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32150460
10.
A New Era in Critical Care Trials: Linking ICU Practice to Long-Term Outcomes.
Am J Respir Crit Care Med
; 209(7): 782-784, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38387023
11.
Future Research Directions in Pneumonia. NHLBI Working Group Report.
Am J Respir Crit Care Med
; 198(2): 256-263, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29546996
12.
Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU.
Am J Respir Crit Care Med
; 198(7): 903-913, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29624409
13.
Oxygen Exposure Resulting in Arterial Oxygen Tensions Above the Protocol Goal Was Associated With Worse Clinical Outcomes in Acute Respiratory Distress Syndrome.
Crit Care Med
; 46(4): 517-524, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29261565
14.
Flow-cytometric method for simultaneous analysis of mouse lung epithelial, endothelial, and hematopoietic lineage cells.
Am J Physiol Lung Cell Mol Physiol
; 310(9): L796-801, 2016 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26944088
15.
Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation.
J Immunol
; 192(9): 4453-4464, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24688024
16.
Regulatory T cell DNA methyltransferase inhibition accelerates resolution of lung inflammation.
Am J Respir Cell Mol Biol
; 52(5): 641-52, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25295995
17.
A Perspective: Division of Lung Diseases at Fifty.
Am J Respir Crit Care Med
; 200(12): 1466-1471, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31657967
18.
Diverse macrophage populations mediate acute lung inflammation and resolution.
Am J Physiol Lung Cell Mol Physiol
; 306(8): L709-25, 2014 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24508730
19.
Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase.
J Immunol
; 189(5): 2234-45, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22844117
20.
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study.
Lancet Reg Health Am
; 31: 100693, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38500962